Check out your Company Bowl for anonymous work chats.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Verily have been collaborating for years across a number of research initiatives. Last week, we announced a $14.7M grant from MJFF to develop a public data resource exploring Parkinson’s disease as it relates to a person’s genetics, immune system and metabolism. The data will be provided to the research community through Verily’s Workbench solution.
Verily nets $14.7M Michael J. Fox Foundation grant for personalized Parkinson's data
Biomedical research thrives on collaboration, but data silos can be a barrier to advance new discoveries and therapies. Join our live webinar on June 3 at 9:30 AM PT to learn how Verily can break down data silos through secure, efficient, and collaborative data sharing and curation to advance research and discovery. Verily experts David Glazer and Shimon Rura will lead the discussion.
Unlock the value of your biomedical health data
Managing clinical trials comes with challenges—disjointed workflows, outdated software, and manual execution against static PDF protocols. There’s a better way to protocol. ICYM our webinar, it's now available on demand. Hear Verily experts Lauren Sutton and Yugang Jia, Ph.D MPH share how Verily Viewpoint Digital Protocols can: ✅ Reduce the time and effort needed to manage trials ✅ Bring drugs to market faster ✅ Drive connections and efficiencies at research sites Plus, get a sneak peek at Verily’s roadmap!
Accelerate Clinical Trials: Unlocking Efficiency with Digital Protocols
Congratulations to our CEO Stephen Gillett for being named to Dallas Innovates' 2025 AI 75 List, an award that recognizes leaders, visionaries, creators, and influencers fueling the growth of artificial intelligence in Dallas-Fort Worth. "We are using large-scale datasets on the Verily platform to advance AI applications and create new methods to make AI fit for purpose for healthcare," said Stephen.
Who Made This Year's AI 75 List? Meet the North Texans Leading the Pack in Artificial Intelligence
We are proud to announce a $14.7M grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to generate one of the world's largest, high-dimensional molecular datasets of Parkinson's patients. This data will be publicly available through Verily Workbench, empowering researchers globally to accelerate the development of new treatments and cures. “Scientific understanding of Parkinson’s disease has advanced significantly over the past decade, and we continue to seek new answers on its genetic, immunological, and molecular determinants,” said Mark Frasier, PhD, Chief Scientist at MJFF.
Verily awarded research grant from The Michael J. Fox Foundation to generate one of the world's largest, high-dimensional molecular datasets of Parkinson's patients | Verily | Alphabet Precision Health Company
Dr. Sarah Thompson is helping pave the way for more individuals with chronic conditions to have access to the right care and support through her work as a Verily clinical expert, healthcare innovator and leader. Read about Sarah's personal story and the experiences that shaped her passion to build effective, safe care programs enabled by Verily technology.
Meet Dr. Sarah Thompson: Chronic care innovator
Hundreds of pages of protocols, 20+ systems… clinical trials are complex. But what if they didn't have to be? Stay tuned for a new Verily N of 1 episode about how Verily is using AI to translate PDF protocols into digital models, partnering with the American Oncology Network to reimagine clinical research. 📷 Behind the scenes with Taylor Stutzman, Research Manager
Hundreds of pages of protocols, 20+ systems… clinical trials are complex. But what if they didn't have to be? Stay tuned for a new Verily N of 1 episode about how Verily is using AI to translate PDF protocols into digital models, partnering with the American Oncology Network to reimagine clinical research. 📷 Behind the scenes with Taylor Stutzman, Research Manager
There are two sessions you won’t want to miss at NACCHO Preparedness Summit 2025 on April 30 in San Antonio, TX! Both feature our Public Health Partnerships Lead Amy Lockwood. ✅ Wastewater Monitoring: An Innovative Tool for Preparing for Large-Scale Events at 8:00 AM ✅ Monitoring and Mitigating the Spread of Vector-Borne Diseases at 4:30 PM
Amy Lockwood - 2025 Preparedness Summit - NACCHO
Balancing your population’s health and cost of care with metabolic conditions is a challenge, especially due to costly GLP-1 medications. Find out how Verily’s personalized, AI-powered approach to care and management will unlock GLP-1 potential for better health while managing costs. Register for the April 30th webinar featuring Verily's Sarah Thompson and David Burdick, Heidi Guetzkow of Aon, and moderator Lydia Ramsey Pflanzer of Endpoints News.
Unlocking GLP-1 potential: Better outcomes, Bigger savings
Protocol Digitization for Clinical Research Sites Move beyond manual PDF protocol management at clinical sites. Verily Viewpoint CTMS uses AI to digitize protocols, optimizing study and financial workflows to enable sites to accelerate studies, prevent errors, and achieve profitability.
Protocol Digitization for Clinical Research Sites